Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mortel

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Cancer Research|September 1, 1976
Decreased prevalence of immediate hypersensitivity (atopy) in a cancer populationJ Allegra, A Lipton, H Harvey, et al.
Gynecologic Oncology|October 1, 1995
Staging and recurrence of disease in squamous cell carcinoma of the vulvaB Ndubisi, P F Kaminski, G Olt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trialF B Stehman, B N Bundy, G Thomas, et al.
Obstetrics and Gynecology|August 1, 1973
The management of carcinoma involving the cervix and body of the uterusJ Antoniades, R Mortel, G C Lewis, et al.
Gynecologic Oncology|May 1, 1988
An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaV R Zurawski, R C Knapp, N Einhorn, et al.
American Journal of Obstetrics and Gynecology|November 1, 1992
Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control studyL A Brinton, M L Berman, R Mortel, et al.
Cancer|May 1, 1977
Plasma prostaglandins across the tumor bed of patients with gynecologic malignancyR Mortel, J C Allegra, L M Demers, et al.
International Journal of Cancer|May 8, 1993
Oral contraceptives and endometrial cancer: do other risk factors modify the association?J L Stanford, L A Brinton, M L Berman, et al.
International Journal of Epidemiology|June 1, 1997
Intrauterine device use and endometrial cancer riskS R Sturgeon, L A Brinton, M L Berman, et al.
Cancer Treatment Reports|February 1, 1979
Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinomaR Kane, H Harvey, T Andrews, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Cancer Research|September 1, 1976
Decreased prevalence of immediate hypersensitivity (atopy) in a cancer populationJ Allegra, A Lipton, H Harvey, et al.
Gynecologic Oncology|October 1, 1995
Staging and recurrence of disease in squamous cell carcinoma of the vulvaB Ndubisi, P F Kaminski, G Olt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trialF B Stehman, B N Bundy, G Thomas, et al.
Obstetrics and Gynecology|August 1, 1973
The management of carcinoma involving the cervix and body of the uterusJ Antoniades, R Mortel, G C Lewis, et al.
Gynecologic Oncology|May 1, 1988
An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaV R Zurawski, R C Knapp, N Einhorn, et al.
American Journal of Obstetrics and Gynecology|November 1, 1992
Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control studyL A Brinton, M L Berman, R Mortel, et al.
Cancer|May 1, 1977
Plasma prostaglandins across the tumor bed of patients with gynecologic malignancyR Mortel, J C Allegra, L M Demers, et al.
International Journal of Cancer|May 8, 1993
Oral contraceptives and endometrial cancer: do other risk factors modify the association?J L Stanford, L A Brinton, M L Berman, et al.
International Journal of Epidemiology|June 1, 1997
Intrauterine device use and endometrial cancer riskS R Sturgeon, L A Brinton, M L Berman, et al.
Cancer Treatment Reports|February 1, 1979
Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinomaR Kane, H Harvey, T Andrews, et al.
Pageof 14